Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/LSI stock hub

FRA/LSI has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/LSIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

782.3M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/LSIFRA/LSI

—

Loading chart…

In the news

Latest news · FRA/LSI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-5.1

P25 n/aP50 n/aP75 n/a

ROIC-1.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/LSI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

183

Groups with data

Currency

HKD

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	DE
Employees	1,920
Employees Change	-98%
Employees Change Percent	-4.82
Enterprise value	EUR 1.4B
Exchange	Frankfurt Stock Exchange
Financial currency	HKD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 782.3M
Price	EUR 0.08
Price currency	EUR
Rev Per Employee	308,339.67x
Sic	2836
Symbol	fra/LSI
Website	https://www.ck-lifesciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.61%
EV Earnings	-70.57x
EV/EBITDA	115.95x
EV/FCF	-227.17x
EV/Sales	2.46x
FCF yield	-0.81%
P/B ratio	1.86x
P/S ratio	1.32x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-2.42%
EBITDA Margin	0.58%
Gross margin	29.15%
Gross Profit	EUR 172.6M
Gross Profit Growth	-6.51%
Gross Profit Growth Q	-12.3%
Gross Profit Growth3 Y	-1.24%
Gross Profit Growth5 Y	-0.83%
Net Income	EUR -20.4M
Pretax Margin	-0.33%
Profit Margin	-3.45%
Profit Per Employee	EUR -10,646
ROA	-0.72
Roa5y	0.7
ROCE	-1.57
ROE	-5.12
Roe5y	-0.28
ROIC	-1.33
Roic5y	0.66

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	0.41%
Cagr15y	6.07%
Cagr1y	-12.72%
Cagr3y	-3%
Cagr5y	1.35%
Div CAGR10	-0.71%
Div CAGR3	0%
Div CAGR5	-2.17%
OCF Growth	-47.12%
OCF Growth Q	-7.27%
OCF Growth10 Y	-9.91%
OCF Growth3 Y	-31.4%
OCF Growth5 Y	-4.07%
Revenue Growth	-2.04x
Revenue Growth Q	-2.86x
Revenue Growth3 Y	0.19x
Revenue Growth5 Y	0.36x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.48
Assets	EUR 1.3B
Cash	EUR 66M
Current Assets	EUR 325.6M
Current Liabilities	EUR 375.5M
Debt	EUR 724.5M
Debt EBITDA	EUR 57.93
Debt Equity	EUR 1.72
Debt FCF	EUR -114
Equity	EUR 420.9M
Interest Coverage	-0.49
Liabilities	EUR 874.4M
Long Term Assets	EUR 969.7M
Long Term Liabilities	EUR 498.9M
Net Cash	EUR -658.5M
Net Cash By Market Cap	EUR -84.18
Net Debt EBITDA	EUR 191
Net Debt Equity	EUR 1.56
Tangible Book Value	EUR 90.7M
Tangible Book Value Per Share	EUR 0.01

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.87
Inventory Turnover	3.21
Net Working Capital	EUR 151.5M
Quick ratio	0.46
Working Capital	EUR -50.5M
Working Capital Turnover	EUR 6.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend per share	EUR 0
Last Dividend	EUR 0

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	4.13%
1Y total return	-12.71%
200-day SMA	0.09
3Y total return	-8.74%
50-day SMA	0.08
50-day SMA vs 200-day SMA	50under200
5Y total return	6.92%
All Time High	0.13
All Time High Change	-39.23%
All Time High Date	2019-11-07
All Time Low	0.01
All Time Low Change	1,216.67%
All Time Low Date	2007-01-24
ATR	0
Ch YTD	-9.71
High	0.08
High52	0.11
High52 Date	2025-10-09
High52ch	-28.18%
Low	0.08
Low52	0.07
Low52 Date	2026-03-27
Low52ch	9.72%
Ma50ch	-1.13%
Price vs 200-day SMA	-14.13%
RSI	52.73
RSI Monthly	50.65
RSI Weekly	40.81
Sharpe ratio	-0.3x
Sortino ratio	-0.27
Tr YTD	-9.71
Tr15y	142.14%
Tr1m	0.64%
Tr1w	2.6%
Tr3m	-9.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -14.3M
Operating margin	-2.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,404,637,115%
Net Borrowing	49,422,935.5
Shares Insiders	22.2%
Shares Institutions	0.7%
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -6.4M
Average Volume	0x
Bv Per Share	0.04
CAPEX	EUR -26.8M
Ch10y	-8.14
Ch15y	102.6
Ch1m	0.64
Ch1w	2.6
Ch1y	-12.71
Ch3m	-9.2
Ch3y	-9.71
Ch5y	2.6
Ch6m	-15.51
Change	0%
Change From Open	0
Close	0.08
Days Gap	0
Depreciation Amortization	17,597,413.5
Earnings Date	2026-05-12
EBIT	EUR -14.3M
EBITDA	EUR 3.4M
EPS	EUR -0
F Score	3
FCF	EUR -6.4M
FCF EV Yield	-0.44x
Financing CF	21,083,390
Fiscal Year End	December
Founded	1,999
Goodwill	302,126,016.8
Income Tax	EUR 18.6M
Investing CF	-37,915,742
Is Primary Listing	0
Last Earnings Date	2026-03-17
Last Report Date	2025-12-31
Ma150	0.09
Ma150ch	-11.14%
Ma20	0.08
Ma20ch	1.67%
Net CF	5,372,421
Next Earnings Date	2026-05-12
Open	0.08
P OCF Ratio	38.24
Ppne	461,811,243.5
Price Date	2026-05-08
Price EBITDA	EUR 227
Ptbv Ratio	8.62
Relative Volume	2,000x
Revenue	592,012,170x
Tax By Revenue	3.15x
Tr6m	-15.51%
Z Score	1.17

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/LSI pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/LSI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/LSI?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.7%

Share of float held by funds and institutions

Insider ownership

+22.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

FRA/LSI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.7

Neutral momentum band

Price vs 200-day MA

-14.1%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.30

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/LSI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/LSI stock rating?

fra/LSI is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/LSI analysis?

The full report lives at /stocks/fra/LSI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/LSI?

The latest report frames fra/LSI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/LSI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.